Organizations throughout the pharmaceutical and life sciences industry are increasing their investments in pharmaceutical and biopharmaceutical development as global demand increases for new and life-saving therapies. In these rapidly-evolving fields, there is a widespread need for application-appropriate, high-value technologies for large and small molecule analysis.

Strategic characterization technologies provide unique insights into the development potential of large molecule therapeutics. A first-line analysis of complex biotherapeutics that is rich with information can save significant time and development costs during production. Waters latest innovations in LC, LC-MS, and informatics are designed to address the multi-faceted analytical needs of large molecule characterization – from innovator biopharmaceuticals, to biosimilars, to antibody drug conjugates – and to keep pace with the regulatory changes that impact development laboratories.

For small molecule analysis, Waters helps pharmaceutical organizations address escalating challenges with sample preparation, separations science, standards and reagents, laboratory information management, liquid chromatography, mass spectrometry, and industry-leading support designed to solve critical analytical problems and increase efficiencies. We help your lab achieve profound discoveries, optimize operations, and ensure regulatory compliance – turning global industry challenges into medicines that offer hope.